3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Precursor Cell Lymphoblastic Leukemia-Lymphoma
5
Recurrence
2
Osteosarcoma
2
Hematologic Neoplasms
2
Wilms Tumor
1
Sarcoma, Ewing
1
Sarcoma, Clear Cell
1
Sarcoma
1
Rhabdomyosarcoma
1
Rhabdoid Tumor
1
Precursor T-Cell Lymphoblastic Leukemia-Lymphoma
1
Neurofibrosarcoma
1
Neuroblastoma
1
Neoplasms, Germ Cell and Embryonal
1
Myelodysplastic Syndromes
1
Melanoma
1
Lymphoma, Non-Hodgkin
1
Leukemia, Myelomonocytic, Juvenile
1
Leukemia, Myeloid, Acute
1
Leukemia, Myelogenous, Chronic, BCR-ABL Positive
1
Leukemia, Lymphoid
1
Leukemia, Large Granular Lymphocytic
1
Leukemia, B-Cell
1
Leukemia
1
Hodgkin Disease
1
Hepatoblastoma
1
Desmoplastic Small Round Cell Tumor
1
Carcinoma
1
Burkitt Lymphoma
1
Blastic Plasmacytoid Dendritic Cell Neoplasm
1
Interventions
Dexamethasone
44
Lenalidomide
29
Bortezomib
23
daratumumab
22
pomalidomide
19
Cyclophosphamide
15
carfilzomib
14
Specimen Handling
14
Biopsy
14
Calcium Dobesilate
12
Magnetic Resonance Spectroscopy
10
talquetamab
9
isatuximab
9
Melphalan
8
iberdomide
7
fludarabine
7
belantamab mafodotin
6
dexamethasone acetate
5
dexamethasone 21-phosphate
5
auricularum
5
X-Rays
5
tocilizumab
4
selinexor
4
fludarabine phosphate
4
elotuzumab
4
Nuclear Medicine Department, Hospital
4
trametinib
3
dabrafenib
3
Whole-Body Irradiation
3
Thalidomide
3
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Multiple Myeloma
×
Mesna
×
30 days
×
Clear all
No trials found.